ArticleBlood cancer journal2014

Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML.

D L Stirewalt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.